SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-064845
Filing Date
2024-03-11
Accepted
2024-03-11 16:30:38
Documents
6
Effectiveness Date
2024-03-11

Document Format Files

Seq Description Document Type Size
1 S-8 d760313ds8.htm S-8 41572
2 EX-5.1 d760313dex51.htm EX-5.1 12027
3 EX-23.1 d760313dex231.htm EX-23.1 1598
4 EX-FILING FEES d760313dexfilingfees.htm EX-FILING FEES 16503
5 GRAPHIC g760313g0309113841918.jpg GRAPHIC 2200
6 GRAPHIC g760313g0325083649189.jpg GRAPHIC 1754
  Complete submission text file 0001193125-24-064845.txt   78561
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277819 | Film No.: 24738475
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)